The future of gene therapy

被引:187
作者
Cavazzana-Calvo, M [1 ]
Thrasher, A
Mavilio, F
机构
[1] Hop Necker Enfants Malad, Immunol & Pediat Haematol Unit, F-75743 Paris 15, France
[2] Inst Child Hlth, London WC1N 1EH, England
[3] Ist Sci H San Raffaele, I-20132 Milan, Italy
[4] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
关键词
D O I
10.1038/427779a
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Balancing the risks and benefits of clinical trial.
引用
收藏
页码:779 / 781
页数:3
相关论文
共 9 条
[1]   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].
Aiuti, A ;
Slavin, S ;
Aker, M ;
Ficara, F ;
Deola, S ;
Mortellaro, A ;
Morecki, S ;
Andolfi, G ;
Tabucchi, A ;
Carlucci, F ;
Marinello, E ;
Cattaneo, F ;
Vai, S ;
Servida, P ;
Miniero, R ;
Roncarolo, MG ;
Bordignon, C .
SCIENCE, 2002, 296 (5577) :2410-2413
[2]   Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99 [J].
Antoine, C ;
Müller, S ;
Cant, A ;
Cavazzana-Calvo, M ;
Veys, P ;
Vossen, J ;
Fasth, A ;
Heilmann, C ;
Wulffraat, N ;
Seger, R ;
Blanche, S ;
Friedrich, W ;
Abinun, M ;
Davies, G ;
Bredius, R ;
Schulz, A ;
Landais, P ;
Fischer, A .
LANCET, 2003, 361 (9357) :553-560
[3]   Side effects of retroviral gene transfer into hematopoietic stem cells [J].
Baum, C ;
Düllmann, J ;
Li, ZX ;
Fehse, B ;
Meyer, J ;
Williams, DA ;
von Kalle, C .
BLOOD, 2003, 101 (06) :2099-2114
[4]   Safety of retroviral gene marking with a truncated NGF receptor [J].
Bonini, C ;
Grez, M ;
Traversari, C ;
Ciceri, F ;
Marktel, S ;
Ferrari, G ;
Dinauer, M ;
Sadat, M ;
Aiuti, A ;
Deola, S ;
Radrizzani, M ;
Hagenbeek, A ;
Apperley, J ;
Ebeling, S ;
Martens, A ;
Kolb, HJ ;
Weber, M ;
Lotti, F ;
Grande, A ;
Weissinger, E ;
Bueren, JA ;
Lamana, M ;
Falkenburg, JHF ;
Heemskerk, MHM ;
Austin, T ;
Kornblau, S ;
Marini, F ;
Benati, C ;
Magnani, Z ;
Cazzaniga, S ;
Toma, S ;
Gallo-Stampino, C ;
Introna, M ;
Slavin, S ;
Greenberg, PD ;
Bregni, M ;
Mavilio, F ;
Bordignon, C .
NATURE MEDICINE, 2003, 9 (04) :367-369
[5]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[6]   Gene therapy insertional mutagenesis insights [J].
Davé, UP ;
Jenkins, NA ;
Copeland, NG .
SCIENCE, 2004, 303 (5656) :333-333
[7]   Primary immunodeficiency diseases: an experimental model for molecular medicine [J].
Fischer, A .
LANCET, 2001, 357 (9271) :1863-1869
[8]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[9]   Gene therapy - New challenges ahead [J].
Williams, DA ;
Baum, C .
SCIENCE, 2003, 302 (5644) :400-401